Teenage Menstrual Pain in Adolescence and Its Link to Increased Risk of Chronic Pain in Adulthood

A groundbreaking study links moderate to severe menstrual pain during adolescence to a higher risk of developing chronic pain in adulthood, emphasizing the importance of proper support and treatment for young people.
Recent research from the University of Oxford reveals that teenagers experiencing moderate to severe menstrual discomfort are at a significantly higher likelihood of developing persistent pain conditions later in life. The study, published in The Lancet Child & Adolescent Health, analyzed data from over 1,100 individuals participating in the long-term Avon Longitudinal Study of Parents and Children (ALSPAC). Findings showed that those reporting severe period pain at age 15 had a 76% increased risk of experiencing chronic pain by age 26, while those with moderate pain faced a 65% higher risk, compared to peers with no reported menstrual pain.
The study indicates that even mild menstrual pain during adolescence can contribute to future health issues, with 17% of teens without initial period pain developing chronic pain later. After accounting for various influencing factors, the data demonstrated a 4.8% higher risk for mild pain, 12.7% for moderate, and 16.2% for severe pain.
This escalating risk pattern was consistent across different types of pain, including headaches, backache, abdominal, and joint discomfort across various body regions. Professor Katy Vincent, a leading gynecologist involved in the research, emphasized that adolescent menstrual pain not only disrupts daily life but may also shape long-term physical health. She highlighted the importance of addressing pain properly, as untreated chronic pain can be challenging to manage and has broad societal impacts.
The researchers propose that changes in the nervous system during adolescence, a period of heightened neuroplasticity, could explain the link. Persistent menstrual pain might cause lasting alterations in how the body processes pain signals, increasing vulnerability to chronic pain conditions.
Furthermore, while mental health issues such as anxiety and depression that develop after menstrual pain contribute only marginally to this relationship, both biological and psychological factors are suspected to play roles. The study advocates for improved menstrual health education and support, aiming to reduce stigma and ensure timely, effective treatment for young people.
Project lead Dr. Rachel Reid-McCann underscores that menstrual pain should never be trivialized, as it can have enduring health consequences. Young people and healthcare providers should approach menstrual discomfort seriously, fostering open communication and support.
The significance of this research lies in the recognition that menstrual pain in adolescence is more than a temporary inconvenience—it's a predictor of potential chronic health issues, demanding attention and action. It highlights the urgent need for better menstrual health policies and research funding to mitigate this long-term risk.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
States Enhance Oversight as Artificial Intelligence Comes to Medical Exam Rooms
States across the U.S. are implementing new regulations to oversee the growing use of artificial intelligence in healthcare, emphasizing transparency, human oversight, and bias reduction to ensure safe and ethical application.
Evolocumab Shows No Benefit in Preventing Vein Graft Disease After Coronary Bypass Surgery, Major Trial Finds
A recent trial reveals that evolocumab, despite significantly lowering LDL cholesterol, does not reduce vein graft disease rates after coronary artery bypass surgery, pointing to the need for novel treatment strategies.
New Insights into How Cancer Cells Develop Resistance to CDK4/6 Inhibitors
New research uncovers how cancer cells create a protective microenvironment that leads to resistance against CDK4/6 inhibitors, opening avenues for improved therapies in breast cancer treatment.
Breakthrough in Bladder Cancer Detection: New Biomarker Identified for Early Diagnosis in Humans and Dogs
Research unveils a novel biomarker, α5β1 integrin, for early detection of bladder cancer in both humans and dogs, paving the way for improved targeted therapies and diagnosis.